Country records 227.5 thousand cases until April; government cites coordinated actions and advancement of new control technologies
Data from the Ministry of Health indicate that dengue cases registered in Brazil during the first months of 2026 fell by 75% compared to the same period last year.
From January to April 11, 227,500 probable cases of the disease were reported compared to 916,400 identified in the same period in 2025. The drop, according to the agency, follows a trend observed since last year, when the total number of cases reached 1.7 million after the peak of 6.6 million recorded in 2024.
In a statement, the ministry assesses that the result reflects the strengthening of coordinated actions with states and municipalities, including strategies such as expanding the use of ovitraps (monitoring traps to combat Aedes aegypti), present in 1,600 municipalities, expected to reach 2,000 by the end of this year.
“The use of irradiated sterile insects and the expansion of the Wolbachia method, expected for 72 priority municipalities, are also advancing.”declared the agency.
VACCINATION
According to the ministry, 1.4 million doses of dengue vaccine were administered to children and adolescents aged 10 to 14, the target audience that has received the vaccine since 2024.
In 2026, the agency began offering the national single-dose vaccine against dengue, developed by the Butantan Institute, in 3 pilot municipalities, for the age group from 12 to 59 years old. Health professionals also receive the vaccine, totaling more than 300 thousand doses applied.
OTHER INFECTIOUS DISEASES
The ministry also released figures related to other infectious diseases registered in the country.
In 2025, Brazil recorded the lowest number of malaria cases since 1979, with a 15% drop compared to the previous year. Cases fell by 30% in total, with a reduction, mainly in indigenous territories. Deaths fell by 28%, from 54 to 39. In the Yanomami Indigenous Land, the reduction was 22% in cases and 80% in deaths.
For the organization, the result is associated with the expansion of diagnosis and treatment, as more than 25,000 patients were treated with tafenoquine. “There was also an intensification of active search and an increase in the offer of rapid tests”.
This text was originally published by , on April 15, 2026, at 3:09 pm. The content is free for republication, the source is cited, and has been adapted to the standard of Poder360.
